# CEVIMELINE HYDROCHLORIDE
> **ANDA216682** · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2023-04-06
## Drug
- **FDA Application Number:** ANDA216682
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CEVIMELINE HYDROCHLORIDE
- **Generic name:** CEVIMELINE HYDROCHLORIDE
- **Active ingredients:** CEVIMELINE HYDROCHLORIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** RUBICON RESEARCH
- **Manufacturer:** Advagen Pharma Ltd
- **First approval:** 2023-04-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216682)
---
*MORVS · CC0 1.0*